Clinical Trial Update: Rifaximin and Placebo in the Treatment of Bowel Dysfunction After Anterior Resection for Rectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing rifaximin to placebo for treating bowel dysfunction after anterior resection for rectal cancer has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Rifaximin (rifaximin)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Rectal Cancer | Phase 3 | Status: COMPLETED | Results posted: 2024-05-14